Skip to main content
OpenTrials

Clinical trial condition

Neoplasms

Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.

7,935 public trials 1,510 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms trial results

Active, Not Recruiting

Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)

NCT05822752

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Arizona Oncology Associates, PC - NAHOA Prescott Valley /ID# 254313 Prescott Valley, Arizona, United States
  • Highlands Oncology Group, PA /ID# 253158 Springdale, Arkansas, United States
  • University of California, Los Angeles /ID# 253292 Los Angeles, California, United States
  • UC Irvine /ID# 252707 Orange, California, United States
View all 59 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating the Safety, Pharmacokinetics (PK), and Preliminary Efficacy of ABBV-399 in Participants With Advanced Solid Tumors

NCT02099058

Conditions
Advanced Solid Tumors Cancer, Neoplasms
Locations
  • Scottsdale Healthcare /ID# 123761 Scottsdale, Arizona, United States
  • City of Hope /ID# 153759 Duarte, California, United States
  • University of California, Los Angeles /ID# 148295 Los Angeles, California, United States
  • UC Irvine /ID# 165107 Orange, California, United States
View all 36 locations
View Trial Details
Active, Not Recruiting

A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET

NCT05482971

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Marin Cancer Care Greenbrae, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 34 locations
View Trial Details
Active, Not Recruiting

A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors

NCT03893955

Conditions
Advanced Solid Tumors, Breast Diseases, Breast Neoplasms, +17 more
Locations
  • Highlands Oncology Group, PA /ID# 218863 Springdale, Arkansas, United States
  • St Jude Hospital dba St Joseph /ID# 211130 Santa Rosa, California, United States
  • Yale University School of Medicine /ID# 210678 New Haven, Connecticut, United States
  • Moffitt Cancer Center /ID# 215037 Tampa, Florida, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC)

NCT06632951

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations
  • Highlands Oncology Group - Springdale /ID# 270290 Springdale, Arkansas, United States
  • University of California San Francisco - Mission Bay /ID# 270289 San Francisco, California, United States
  • Yale University School of Medicine /ID# 270449 New Haven, Connecticut, United States
  • Medical Oncology Hematology Consultants /ID# 271347 Newark, Delaware, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer

NCT05226507

Conditions
ARID1A Gene Mutation, Adenocarcinoma, Adnexal Diseases, +24 more
Locations
  • Honor Health Phoenix, Arizona, United States
  • UC San Diego Health - Moores Cancer Center La Jolla, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Yale Gynecologic Oncology New Haven, Connecticut, United States
View all 22 locations
View Trial Details
Active, Not Recruiting

A Study to Assess Adverse Events and Change in Disease State of Intravenously (IV) Infused Etentamig (ABBV-383) of Adult Participants With Relapsed or Refractory Multiple Myeloma in Japan

NCT05286229

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • National Cancer Center Hospital East /ID# 240943 Kashiwa-shi, Chiba, Japan
  • Hokkaido University Hospital /ID# 242672 Sapporo, Hokkaido, Japan
  • Kanazawa University Hospital /ID# 240948 Kanazawa, Ishikawa-ken, Japan
  • Duplicate_Okayama Medical Center /ID# 240949 Okayama, Okayama-ken, Japan
View Trial Details

Related conditions